Diana B Pedral-Sampaio

Summary

Affiliation: Universidade Federal da Bahia
Country: Brazil

Publications

  1. ncbi request reprint Efficacy and safety of Efavirenz in HIV patients on Rifampin for tuberculosis
    Diana B Pedral-Sampaio
    Federal University of Bahia, Salvador, BA, Brazil
    Braz J Infect Dis 8:211-6. 2004
  2. ncbi request reprint Risk of tuberculosis among household contacts in Salvador, Bahia
    Antonio Carlos Lemos
    Prof Edgard Santos Universitary Hospital, Federal University of Bahia, Rua Joao das Botas, S N 6o andar, Sala 1124 Canela, 40110 160 Salvador, Bahia, Brazil
    Braz J Infect Dis 8:424-30. 2004
  3. ncbi request reprint Treating tuberculosis in AIDS patients: when to start and how long to keep giving drugs?
    Diana B Pedral-Sampaio
    AIDS 16:1845. 2002

Collaborators

  • Antonio Carlos Lemos
  • Eduardo M Netto
  • Eliana D Matos

Detail Information

Publications3

  1. ncbi request reprint Efficacy and safety of Efavirenz in HIV patients on Rifampin for tuberculosis
    Diana B Pedral-Sampaio
    Federal University of Bahia, Salvador, BA, Brazil
    Braz J Infect Dis 8:211-6. 2004
    ..We conclude that Efavirenz at a daily dose of 600 mg is sufficient and safe to treat HIV/TB patients using a Rifampin containing regimen...
  2. ncbi request reprint Risk of tuberculosis among household contacts in Salvador, Bahia
    Antonio Carlos Lemos
    Prof Edgard Santos Universitary Hospital, Federal University of Bahia, Rua Joao das Botas, S N 6o andar, Sala 1124 Canela, 40110 160 Salvador, Bahia, Brazil
    Braz J Infect Dis 8:424-30. 2004
    ..Tuberculosis is one of the most important infectious diseases in the world. Only 68% of the estimated new tuberculosis (TB) cases in Brazil are diagnosed. Our aim was to determine the risk of infection among household contacts...
  3. ncbi request reprint Treating tuberculosis in AIDS patients: when to start and how long to keep giving drugs?
    Diana B Pedral-Sampaio
    AIDS 16:1845. 2002